Litcius/Paper detail

Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery

Seok-Joo Chun, Kyubo Kim, Yong Bae Kim, Sun Ha Paek, Kyung-Hun Lee, Jin‐Ho Song, Won Il Jang, Tae Hyun Kim, Viola Salvestrini, Icro Meattini, Lorenzo Livi, Kyung Hwan Shin

2024Radiotherapy and Oncology12 citationsDOI

Topics & Concepts

Trastuzumab emtansineRadiosurgeryBrain metastasisMedicineOncologyTrastuzumabBreast cancerInternal medicineCancerMetastasisRadiation therapyBrain Metastases and TreatmentHER2/EGFR in Cancer ResearchLung Cancer Research Studies
Risk of radionecrosis in HER2-positive breast cancer with brain metastasis receiving trastuzumab emtansine (T-DM1) and brain stereotactic radiosurgery | Litcius